TP-03

· Tarsus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TP-03, covering 2023-12-21 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD [Phase 2]